KLK3 and pachyonychia congenita: The Japanese Radiation Oncology Study Group conducted a multi-institutional retrospective study of S-RT for PC patients with BR and found the PSA level before S-RT to be a predictive marker of BR, but PSA kinetics were not evaluated because of a lack of data during and after S-RT [13].